Distribution and 24-hour transition of SCAI shock stages and their association with 30-day mortality in acute myocardial infarction
Hung Manh Pham1,2, Hanh Duc Van1, Long Bao Hoang3
1Vietnam National Heart Institute, Bach Mai Hospital, Hanoi, Vietnam.
Insights
Monitoring Society for Cardiovascular Angiography and Interventions (SCAI) shock stages in acute myocardial infarction (AMI) patients after admission improves mortality prediction. Changes in SCAI stage within 24 hours offer crucial prognostic information for AMI patients.
Area of Science:
- Cardiology
- Critical Care Medicine
- Clinical Research
Background:
- The Society for Cardiovascular Angiography and Interventions (SCAI) shock classification is a validated predictor of mortality in acute myocardial infarction (AMI).
- Limited data exist on the dynamic changes in SCAI shock stages post-AMI and their correlation with patient outcomes.
- Understanding SCAI stage transitions is crucial for refining prognostic assessments in AMI patients.
Purpose of the Study:
- To investigate the association between transitions in SCAI shock stages and 30-day mortality in patients with AMI.
- To determine if reevaluating SCAI stages after 24 hours provides additional prognostic value beyond initial assessment.
Main Methods:
- A prospective study included 139 AMI patients classified by SCAI stages (A, B, C/D/E) at admission and 24 hours.
- Kaplan-Meier estimates and multivariable Cox regression analyses were used to assess the relationship between SCAI stage changes and 30-day mortality.
- Patients were categorized based on initial SCAI stage and changes observed within 24 hours.
Main Results:
- On admission, 50.4% were SCAI stage A, 20.1% stage B, and 29.5% stages C/D/E.
- After 24 hours, 14.4% improved, 66.2% remained stable, and 19.4% worsened.
- 30-day mortality rates were 2.9% (initial A), 21.4% (initial B), and 61.0% (initial C/D/E). Mortality was significantly higher (92.6%) in patients whose SCAI stage worsened by 24 hours.
Conclusions:
- Dynamic assessment of SCAI shock stages in AMI patients, both at admission and after 24 hours, significantly enhances 30-day mortality prediction.
- Worsening SCAI stage within 24 hours is strongly associated with increased mortality.
- Serial SCAI staging provides valuable prognostic information for managing AMI patients.
Abstract:
The Society for Cardiovascular Angiography and Interventions (SCAI) shock classification has been shown to predict mortality in acute myocardial infarction (AMI). However, data on the transition of SCAI stages and their association with mortality after AMI are limited. All patients with AMI admitted to Vietnam National Heart Institute between August 2022 and February 2023 were classified into SCAI stages A, B, and C/D/E at admission and were reevaluated in 24 hours. We used Kaplan-Meier estimate and multivariable Cox regression analysis to assess the association between SCAI stages transition and 30-day mortality. We included 139 patients (median age 69 years, 29.5% female). On admission, 50.4%, 20.1%, and 29.5% of patients were classified as SCAI stage A, B, and C/D/E, respectively. The proportion of patients whose SCAI stage improved, remained stable, or worsened after 24 hours was 14.4%, 66.2%, and 19.4%, respectively. The 30-day mortality in patients with initial SCAI stages A, B, and C/D/E on admission was 2.9%, 21.4%, and 61.0%, respectively (P < .001). The 30-day mortality was 2.4% for patients with baseline SCAI stage A/B who remained unchanged or improved, 30.0% for patients with baseline SCAI stage C/D/E who remained unchanged or improved, and 92.6% for patients with SCAI stage B/C/D/E who worsened at 24 hours after admission (log-rank P < .001). In patients with AMI, evaluating the SCAI stage shock stage on admission and reevaluating after 24 hours added more information about 30-day mortality.
More Related Videos
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
06:10Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome V: Nursing Management
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
